| BCBS Florida Coverage Guidelines | Eribulin Mesylate (Halaven®) Injection (09-J1000-76) | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Exon-Skipping Therapy for Duchenne (09-J3000-93) | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Human EGFR Inhibitors (Cetuximab (09-J0000-94) | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Injectable Iron Therapy [Ferric (09-J2000-10) | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Irinotecan Liposome Injection (Onivyde™) (09-J2000-52) | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Lecanemab-irmb (Leqembi, Leqembi Iqlik) (09-J4000-41) | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Levoleucovorin (Fusilev® and Khapzory™) IV (09-J2000-31) | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Loncastuximab Tesirine-lpyl (Zynlonta®) IV (09-J4000-05) | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Margetuximab-cmkb (Margenza™) (09-J3000-88) | 2026-06-01 |
| BCBS Florida Coverage Guidelines | Melphalan HCl, Captisol-Enabled (Evomela®) (09-J2000-61) | 2026-06-01 |